Fig. 3.
Gene transfer of SOD3 protects aorta against XO-mediated vasomotor dysfunction. Following gene transfer of SOD3, (A) dose-dependent relaxation to ACh in the absence or presence of XO was determined. Gene transfer of β-galactosidase serves as negative control and exogenously applied bovine SOD (500 U/ml) serves as positive control. (n=6–10) ⁎p<0.05 vs Adβgal without XO. (B) Maximal relaxation to ACh based on non-linear curve fit of data in (A). ⁎p<0.05 vs Adβgal without XO; +p<0.05 Adβgal with XO. (C) EC50 relaxation to ACh based on non-linear curve fit of data in (A). (D) Lucigenin-enhanced chemiluminescence of xanthine/XO in the presence or absence of bovine SOD (n=3); p<0.05.